Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Moderna, Inc. - Common Stock (NQ:MRNA)

41.60 +0.59 (+1.44%)
Streaming Delayed Price Updated: 10:53 AM EST, Feb 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Moderna, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Clover Health, GoodRx, Moderna, UFP Technologies, and Masimo Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated... 
Via StockStory
Topics Economy
News headline image
Walmart, Intuit, The Gap, SanDisk And Moderna: Why These 5 Stocks Are On Investors' Radars Today ↗
WMT, INTU, GAP, SNDK, MRNA were the stocks seen trending on Thursday, Nov. 20, 2025. 
Via Benzinga
News headline image
AI Unleashes a Healthcare Revolution: Smarter Care, Empowered Providers, Healthier Nation
Artificial intelligence is rapidly transforming America's healthcare system, offering immediate and profound benefits across the entire spectrum of care, from individual patients to providers and... 
Via TokenRing AI
Topics Artificial Intelligence
Moderna Procures $1.5B Loan To Grow Its Pipeline Beyond Vaccines ↗
Via Stocktwits
News headline image
What's Going On With Moderna Stock? ↗
Shares of Moderna are falling Thursday. The company made two significant announcements regarding its finances and business strategy. 
Via Benzinga
News headline image
Moderna Analyst Day Highlights Pipeline Progress and Business Strategy Updates
Via ACCESS Newswire
News headline image
Moderna Secures $1.5 Billion Five-Year Credit Facility from Ares Management
Via ACCESS Newswire
News headline image
Moderna Brings Back Drug Product Manufacturing To Home Ground ↗
The company said it has commenced construction at the Massachusetts facility, which is slated for completion in the first half of 2027. 
Via Stocktwits
News headline image
Moderna Expands U.S. Manufacturing with Onshoring of Drug Product Capabilities
Via ACCESS Newswire
News headline image
Moderna to Present at Upcoming Piper Sandler's 37th Annual Healthcare Conference on December 2, 2025
Via ACCESS Newswire
News headline image
1 Cash-Heavy Stock to Target This Week and 2 That Underwhelm
A surplus of cash can mean financial stability, but it can also indicate a reluctance (or inability) to invest in growth. Some of these companies also face challenges like stagnating revenue, declining... 
Via StockStory
News headline image
The Tech Tsunami: How Breakthroughs in AI, Quantum, and Green Energy Are Reshaping the Stock Market
The global financial markets are in the midst of a profound transformation, driven by an accelerating wave of technological advancements. From the intricate algorithms of Artificial Intelligence to the... 
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
News headline image
Friday's session: gap up and gap down stock in the S&P500 index ↗
Wondering which stocks are making significant price gaps? Explore the S&P500 index on Friday to find the gap up and gap down stocks in today's session. 
Via Chartmill
News headline image
Merck Makes Big Bet On Flu Protection With Cidara Buyout ↗
Merck (NYSE: MRK) to acquire Cidara (NASDAQ: CDTX) for $9.2 billion, diversifying its portfolio with CD388. 
Via Benzinga
News headline image
5 Insightful Analyst Questions From Moderna’s Q3 Earnings Call
Moderna’s third quarter was shaped by sharply lower demand for COVID-19 vaccines, yet the company delivered results above Wall Street expectations for both revenue and earnings. Management attributed... 
Via StockStory
Topics Earnings
News headline image
3 Small-Cap Stocks with Warning Signs
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside... 
Via StockStory
News headline image
Gilead Sciences, Moderna, Artivion, Tenet Healthcare, and Charles River Laboratories Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid... 
Via StockStory
Topics Artificial Intelligence Stocks
News headline image
Exploring the top movers within the S&P500 index during today's session. ↗
Get insights into the S&P500 index performance on Tuesday. Explore the top gainers and losers within the S&P500 index in today's session. 
Via Chartmill
News headline image
Q3 Rundown: Moderna (NASDAQ:MRNA) Vs Other Therapeutics Stocks
Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at Moderna (NASDAQ:MRNA) and its peers. 
Via StockStory
Topics Artificial Intelligence
News headline image
Healthcare Sector Navigates Turbulent Waters: Innovation Surges Amidst Political Headwinds
New York, NY – November 10, 2025 – The S&P 500 Healthcare sector presented a mixed picture today, with the broader index showing a modest uptick while significant segments, particularly health insurers... 
Via MarketMinute
Topics Artificial Intelligence Economy Government
News headline image
Telemark Asset Management Builds Position in Beaten-Down Biotech Stock. ↗
Telemark Asset Management Builds Position in Beaten-Down Biotech Stock. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
S&P 500 Breaches Key Support: A Signal of Deepening Market Weakness
The S&P 500 index has recently fallen below its crucial 50-day moving average, a technical event that is sending ripples of concern throughout global financial markets. This breach, occurring as of... 
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
News headline image
Wall Street Slips as Job Cuts and Shutdown Fears Shake Confidence ↗
Investors brace for weaker labor data and prolonged government paralysis while AI-fueled volatility rattles the markets. 
Via Chartmill
News headline image
MRNA Q3 Deep Dive: Cost Controls and Pipeline Progress Amid Declining COVID Vaccine Demand
Biotechnology company Moderna (NASDAQ:MRNA) reported revenue ahead of Wall Streets expectations in Q3 CY2025, but sales fell by 45.4% year on year to $1.02 billion. On the other hand, the company’s... 
Via StockStory
News headline image
AI Stocks Slide Again, Bitcoin Dips Near $100,000: What's Moving Markets Thursday? ↗
After a brief and cautious rebound on Wednesday, risk-off sentiment returned sharply on Thursday, with AI-linked stocks leading a broad selloff across Wall Street and renewed pressure hitting crypto... 
Via Benzinga
Topics Artificial Intelligence
News headline image
mRNA Vaccine Maker Moderna Lowers R&D Spending, Tightens Sales Forecast ↗
Moderna posts a smaller Q3 loss, trims 2025 sales forecast, cuts R&D costs, and boosts cash outlook as COVID vaccine demand declines. 
Via Benzinga
News headline image
Moderna Q3 2025 Earnings Call Transcript ↗
Moderna reported third-quarter financial results on Thursday. The transcript from the company's earnings call has been provided below. 
Via Benzinga
Topics Earnings
News headline image
Stay updated with the S&P500 stocks that are on the move in today's pre-market session. ↗
Before the US market kicks off on Thursday, let's examine the pre-market session and unveil the notable performers among the S&P500 top gainers and losers. 
Via Chartmill
News headline image
Moderna Inc (NASDAQ:MRNA) Reports Q3 2025 Revenue Beat and Narrower-Than-Expected Loss ↗
Moderna's Q3 2025 earnings beat revenue estimates with $1.016B and a narrower loss. Shares rose on strong COVID vaccine sales and an improved 2025 financial outlook. 
Via Chartmill
Topics Earnings
News headline image
Moderna Surges; Covid Vaccine Sales Decline, But Top Expectations ↗
Moderna stock surged Thursday. Though third-quarter vaccine sales declined, they came in above expectations. 
Via Investor's Business Daily
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.